The EMA has taken a huge step towards IDMP implementation with the go live of the Product Management Service (PMS) and integration of PMS data into the e-Application Form (eAF).  

There are now broader requirements to submit information to XEVMPD to make sure that products are available in the eAF and correctly presented in PMS. Marketing Authorization Holders also need to begin reviewing PMS data, submitting information on structured pack sizes and manufacturers and getting ready for further enrichment activities. 

Many of these deadlines are more pressing for products that appear on the Union List of Critical Medicines, but it’s vital to consider how you will meet the requirements for the whole portfolio to ensure compliance.